BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,056 filers reported holding BAXTER INTL INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,493,729 | -74.8% | 1,443,925 | -69.5% | 0.02% | -74.7% |
| Q2 2023 | $216,019,095 | +112676.0% | 4,741,420 | +0.4% | 0.08% | +5.6% |
| Q1 2023 | $191,547 | -55.4% | 4,722,578 | -44.0% | 0.07% | -57.5% |
| Q4 2022 | $429,613 | -99.9% | 8,428,732 | +11.6% | 0.17% | +1.2% |
| Q3 2022 | $406,901,000 | +75.3% | 7,554,781 | +109.1% | 0.16% | +83.3% |
| Q2 2022 | $232,090,000 | -22.5% | 3,613,410 | -4.6% | 0.09% | -7.2% |
| Q1 2022 | $299,431,000 | -33.1% | 3,787,859 | -27.4% | 0.10% | -26.5% |
| Q4 2021 | $447,682,000 | +4.8% | 5,215,309 | -1.8% | 0.13% | 0.0% |
| Q3 2021 | $427,059,000 | +4.3% | 5,309,697 | +4.4% | 0.13% | +8.2% |
| Q2 2021 | $409,405,000 | -29.3% | 5,085,785 | -25.9% | 0.12% | -33.7% |
| Q1 2021 | $579,121,000 | -4.4% | 6,866,496 | -9.0% | 0.18% | -10.2% |
| Q4 2020 | $605,488,000 | +9.5% | 7,545,972 | +9.8% | 0.20% | -3.8% |
| Q3 2020 | $552,833,000 | +18.2% | 6,874,316 | +26.6% | 0.21% | +12.1% |
| Q2 2020 | $467,586,000 | -28.1% | 5,430,729 | -32.2% | 0.19% | -40.1% |
| Q1 2020 | $650,473,000 | +8.5% | 8,011,729 | +11.7% | 0.32% | +39.6% |
| Q4 2019 | $599,508,000 | +59.3% | 7,169,424 | +66.7% | 0.23% | +49.3% |
| Q3 2019 | $376,263,000 | +8.6% | 4,301,623 | +1.7% | 0.15% | +11.8% |
| Q2 2019 | $346,392,000 | +18344.7% | 4,229,457 | +18207.8% | 0.14% | +1260.0% |
| Q1 2019 | $1,878,000 | +23.4% | 23,102 | -0.1% | 0.01% | 0.0% |
| Q4 2018 | $1,522,000 | -75.3% | 23,118 | -71.1% | 0.01% | -69.7% |
| Q3 2018 | $6,158,000 | +529.7% | 79,879 | +503.0% | 0.03% | +450.0% |
| Q2 2018 | $978,000 | -27.6% | 13,247 | -36.2% | 0.01% | -33.3% |
| Q1 2018 | $1,350,000 | +4.0% | 20,753 | +3.4% | 0.01% | +12.5% |
| Q4 2017 | $1,298,000 | -82.4% | 20,073 | -83.0% | 0.01% | -83.3% |
| Q3 2017 | $7,394,000 | -29.2% | 117,825 | -31.7% | 0.05% | -28.4% |
| Q2 2017 | $10,445,000 | +19.6% | 172,524 | +2.5% | 0.07% | +28.8% |
| Q1 2017 | $8,731,000 | -19.1% | 168,351 | -30.8% | 0.05% | -5.5% |
| Q4 2016 | $10,787,000 | +46.1% | 243,285 | +56.8% | 0.06% | +27.9% |
| Q3 2016 | $7,384,000 | +296.3% | 155,130 | +276.6% | 0.04% | +290.9% |
| Q2 2016 | $1,863,000 | +6.3% | 41,196 | -3.4% | 0.01% | +22.2% |
| Q1 2016 | $1,752,000 | +6.4% | 42,657 | -1.2% | 0.01% | +12.5% |
| Q4 2015 | $1,647,000 | +14.0% | 43,178 | -1.8% | 0.01% | 0.0% |
| Q3 2015 | $1,445,000 | -13.6% | 43,978 | -0.1% | 0.01% | -11.1% |
| Q2 2015 | $1,673,000 | -44.7% | 44,034 | -0.4% | 0.01% | -47.1% |
| Q1 2015 | $3,027,000 | -6.2% | 44,196 | +0.4% | 0.02% | -5.6% |
| Q4 2014 | $3,227,000 | +25.8% | 44,034 | +23.2% | 0.02% | +12.5% |
| Q3 2014 | $2,565,000 | -6.1% | 35,744 | -5.4% | 0.02% | -5.9% |
| Q2 2014 | $2,732,000 | -18.5% | 37,784 | -17.0% | 0.02% | -15.0% |
| Q1 2014 | $3,351,000 | +3.7% | 45,542 | -2.0% | 0.02% | -4.8% |
| Q4 2013 | $3,232,000 | +0.5% | 46,463 | -5.1% | 0.02% | 0.0% |
| Q3 2013 | $3,215,000 | -35.7% | 48,938 | -32.2% | 0.02% | -38.2% |
| Q2 2013 | $5,001,000 | – | 72,201 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |